Literature DB >> 27454734

Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.

.   

Abstract

Immediate postpartum long-acting reversible contraception (LARC) has the potential to reduce unintended and short-interval pregnancy. Women should be counseled about all forms of postpartum contraception in a context that allows informed decision making. Immediate postpartum LARC should be offered as an effective option for postpartum contraception; there are few contraindications to postpartum intrauterine devices and implants. Obstetrician-gynecologists and other obstetric care providers should discuss LARC during the antepartum period and counsel all pregnant women about options for immediate postpartum initiation. Education and institutional protocols are needed to raise clinician awareness and to improve access to immediate postpartum LARC insertion. Obstetrician-gynecologists and other obstetric care providers should incorporate immediate postpartum LARC into their practices, counsel women appropriately about advantages and risks, and advocate for institutional and payment policy changes to support provision.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27454734     DOI: 10.1097/AOG.0000000000001587

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  44 in total

1.  Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults.

Authors:  Somsook Santibenchakul; Mary Tschann; Alyssa Dee P Carlson; Eric L Hurwitz; Jennifer Salcedo
Journal:  J Midwifery Womens Health       Date:  2018-12-20       Impact factor: 2.388

2.  Application of an Implementation Science Framework to Policies on Immediate Postpartum Long-Acting Reversible Contraception.

Authors:  Carla L DeSisto; Charlan D Kroelinger; Cameron Estrich; Alisa Velonis; Keriann Uesugi; David A Goodman; Ellen Pliska; Sanaa Akbarali; Kristin M Rankin
Journal:  Public Health Rep       Date:  2019-01-30       Impact factor: 2.792

3.  Meeting the Contraceptive Needs of a Community: Increasing Access to Long-Acting Reversible Contraception.

Authors:  Colleen McNicholas; Tessa Madden
Journal:  Mo Med       Date:  2017 May-Jun

4.  Prevalence and Predictors of Prenatal and Postpartum Contraceptive Counseling in Two Texas Cities.

Authors:  Kate Coleman-Minahan; Abigail R A Aiken; Joseph E Potter
Journal:  Womens Health Issues       Date:  2017-06-27

5.  Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates.

Authors:  Mary Montague; Mustafa Ascha; Barbara Wilkinson; Emily Verbus; Jane Morris; Brian M Mercer; Kavita Shah Arora
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

6.  Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.

Authors:  Michelle H Moniz; Tammy Chang; Michele Heisler; Lindsay Admon; Acham Gebremariam; Vanessa K Dalton; Matthew M Davis
Journal:  Obstet Gynecol       Date:  2017-06       Impact factor: 7.661

7.  Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder.

Authors:  Elizabeth E Krans; Joo Yeon Kim; Alton Everette James; David K Kelley; Marian Jarlenski
Journal:  Drug Alcohol Depend       Date:  2018-02-14       Impact factor: 4.492

8.  Postpartum Contraceptive Use Among Denver-Based Adolescents and Young Adults: Association with Subsequent Repeat Delivery.

Authors:  Margo S Harrison; Rachel Zucker; Sharon Scarbro; Carter Sevick; Jeanelle Sheeder; Arthur J Davidson
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-04-03       Impact factor: 1.814

9.  Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study.

Authors:  Reni Soon; Katie McGuire; Jennifer Salcedo; Bliss Kaneshiro
Journal:  Hawaii J Med Public Health       Date:  2018-03

10.  Impact of training level on postplacental levonorgestrel 52 mg intrauterine device expulsion.

Authors:  Madeline Cole; Stephanie Thomas; Brian M Mercer; Kavita Shah Arora
Journal:  Contraception       Date:  2018-11-16       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.